Although communication about COVID-19 between top Canadian and U.S. public health officials has been limited based on access to information records, some information released by the Canadian government has been countered by the Chief Public Health Officer. Indicates that you are seeking advice from the part.
The Epoch Times filed Access to Information (ATIP) requests for all communications between Public Health Agency of Canada (PHAC) officials and leaders in the same field in the United States, such as the Centers for Disease Control and Prevention (CDC). bottom. Director Rochelle Walensky and her Anthony Fauci, the recently retired Director of the National Institute of Allergy and Infectious Diseases (NIAID).
The request returned a total of 3 emails. Two of them were Federal Chief Public Health Officer Dr. Teresa Tam, who sends her PHAC annual report to her CDC staff whose names have been redacted.
An email unrelated to the Annual Report was sent on December 20, 2021 with the subject line “Request for Assistance Regarding the Use of Oral Antivirals for COVID-19.”
“I hope you are doing well as the Omicron case escalates into the holiday season,” Dr. Tam wrote.
The omicron variant of the SARS-CoV-2 virus was discovered weeks ago and will soon infect large numbers of people, vaccinated or not.
Tam said PHAC is “convening a group of experts to consider the most effective use of Pfizer’s antiviral drug Paxlovid while it awaits regulatory approval.”
Pfizer submitted data on its oral antiviral drug Paxlovid to Health Canada on December 1, 2021. announced After expedited review, the drug was approved on January 17, 2022.
“Could you link us to experts at the CDC or elsewhere in the US who are working on guidance, including recommendations for priority groups that could benefit from initial supply,” Tam said of his identity. I asked an unknown U.S. official.
The U.S. Food and Drug Administration (FDA) has announced emergency use authorization for paxlobid on December 22, 2021.
CDC employees who responded had the designation “(CDC/OD)” after their name, indicating a job in the director’s office.
“I hope you’re doing well too. Times are somewhat unforgiving,” the U.S. official replied.
“I’m cc [redacted] Now, who is the best person for you to link to at the CDC? [part of sentence redacted]If we could bring in someone from the FDA if necessary. ”
press release collaboration
Dr. Tam’s most recent email provided in the disclosure is dated November 1, 2022.
She shared with the unidentified CDC chief executive PHAC’s annual report titled “Mobilizing Public Health Action Against Climate Change.”
“Thank you for your cooperation earlier this year with our press release regarding the availability of vaccinations and booster shots,” she wrote at the beginning.
No details were given in the press release or the exact nature of the collaboration. We contacted PHAC for details.
Presenting his report as a “unique contribution to the global discourse,” Tam said, “How the public health system can build on its strengths and the experience of COVID-19 to better respond to the climate crisis.” provided fairness-focused recommendations for
“This is an important time for public health to continue its leadership. We have the tools to understand climate change and how to address this complex and growing challenge.”
Another email to CDC officials related to Tam’s sharing of PHAC’s 2021 report was made based on World Health Organization (WHO) “building blocks,” she said.
“Based on these building blocks, my vision for public health transformation in Canada was established and is further elaborated in the report.”
At ATIP’s request, emails between US officials and PHAC President Dr. Harpreet S. Kochhar or Deputy Chief Public Health Officer Dr. Howard Njoo were never released.